Respiratory

Latest News

Given the observed outcomes, camlipixant merits further study in severe RCC, especially among patients with a high initial cough burden. | Image credit: sebra - stock.adobe.com
Camlipixant May Benefit Patients With High-Burden RCC

June 25th 2025

A phase 2a trial of camlipixant, a selective P2X3 receptor antagonist, found that while the drug did not significantly reduce cough frequency in the overall population with refractory chronic cough, it produced meaningful improvements in patients with a higher baseline cough burden.

Man having asthma attack on couch | Image credit: Pixel-Shot – stock.adobe.com
Solrikitug Shows Promise as Next-Generation Anti-TSLP Therapy in Asthma, COPD

June 25th 2025

A comprehensive home-based program integrating weekly telecounseling and individually tailored breathing exercise training reduced hospitalizations among patients with COPD. | Image credit: Ahmad - stock.adobe.com
Telehealth Model Reduces Hospital Admissions in COPD

June 18th 2025

FDA Approval | Image credit: BHM – stock.adobe.com
FDA Approves Clesrovimab to Prevent RSV in Infants During First Season

June 10th 2025

In the new report, the authors aimed to see how well the REOM device would perform in a cohort of adults with COPD. | Image credit: Elena - stock.adobe.com
Handheld Device Could Simplify COPD Monitoring

May 28th 2025

Continuing Medical Education
View All
June 29th 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology
June 29th 2025

Managing Patients With COPD: Evidence-Based Care and Optimizing Value of New and Emerging Targeted Therapies

1.0 Credit / Immunology, Pulmonology/Respiratory
June 29th 2025

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health
June 29th 2025

Updated Guidance and Managed Care Strategies to Optimize Respiratory Syncytial Virus Vaccination Coverage

1.5 Credits / Immunization, Infectious Disease, Pulmonology
June 29th 2025

Reflecting on the Real-World Use of Biologic Therapy in Asthma Management

1.5 Credits / Immunology, Pulmonology
June 29th 2025

Advancing Cystic Fibrosis Management: The Evolving Role of Specialty and Managed Care Pharmacists

1.5 Credits / Pulmonology
June 29th 2025

Pulmonary Arterial Hypertension: Real-World Applications of New Therapies and Management Strategies

1.5 Credits / Pulmonology, Cardiology, Rare Diseases

More News

Site Logo
February 17th 2018

Claims-Based Risk Model for First Severe COPD Exacerbation

Richard H. Stanford, PharmD, MS Arpita Nag, PhD, MBA, MS Douglas W. Mapel, MD Todd A. Lee, PhD Richard Rosiello, MD Michael Schatz, MD Francis Vekeman, MS Marjolaine Gauthier-Loiselle, PhD J.F. Philip Merrigan, PhD Mei Sheng Duh, ScD
A health insurance claims-based risk assessment tool to predict patients’ first severe chronic obstructive pulmonary disease exacerbation has been developed and validated.
Respimat Is First Inhaler to Receive Award for Ease of Use for People With Arthritis
January 24th 2018

Respimat Is First Inhaler to Receive Award for Ease of Use for People With Arthritis

AJMC Staff
Respimat from Boehringer Ingelheim is now the first and only inhaler to be awarded the Ease of Use Commendation by the Arthritis Foundation. This award identifies products that make life easier for people with arthritis and other physical limitations.
Researchers Make COPD Genetic Discovery That Could Identify At-Risk Patients Earlier
January 16th 2018

Researchers Make COPD Genetic Discovery That Could Identify At-Risk Patients Earlier

Allison Inserro
Cigarette smoking is the most common cause of chronic obstructive pulmonary disease (COPD), but not all smokers develop the condition, and many non-smokers do. Why that is has remained a mystery until now, as a research team, funded by the National Institutes of Health, has discovered genetic variations in the anatomy of the lungs could serve as early-warning indicators.
CDC Study Puts Economic Burden of Asthma at More Than $80 Billion Per Year
January 12th 2018

CDC Study Puts Economic Burden of Asthma at More Than $80 Billion Per Year

Allison Inserro
Asthma costs the U.S. economy more than $80 billion annually in medical expenses, days missed from work and school, and deaths, according to research published online in the Annals of the American Thoracic Society. However, actual numbers are likely to be higher, according to CDC researchers who conducted the study.
Study Shows Psychological Factors Affect Quality of Life in Patients With COPD
January 10th 2018

Study Shows Psychological Factors Affect Quality of Life in Patients With COPD

Kaitlynn Ely
Psychological factors negatively affect quality-of-life scores in chronic obstructive pulmonary disease (COPD) patients, according to a recent study published in the International Journal of Chronic Obstructive Pulmonary Disease.
Study Shows the Efficacy of Vaccination in Patients With COPD
January 3rd 2018

Study Shows the Efficacy of Vaccination in Patients With COPD

Kaitlynn Ely
Patients with chronic obstructive pulmonary disease should be given the pneumococcal conjugate vaccine and influenza vaccines to decrease the risk of exacerbations. However, despite the evidence of vaccine efficacy, improvements are needed in coverage and awareness.
Researchers Find Low Referral Rates to Pulmonary Rehab for Eligible Patients With COPD
December 25th 2017

Researchers Find Low Referral Rates to Pulmonary Rehab for Eligible Patients With COPD

Christina Mattina
Less than 10% of patients with chronic obstructive pulmonary disease (COPD) who may benefit from pulmonary rehabilitation received a referral from their physician, according to a new study. However, there was no association found between referral status and COPD exacerbations.
Boxed Warning for Asthma Death Risk Removed From ICS/LABA Drugs
December 24th 2017

Boxed Warning for Asthma Death Risk Removed From ICS/LABA Drugs

AJMC Staff
The FDA has removed a boxed warning on medicines delivering a combinations of inhaled corticosteroid (ICS) and long-acting beta agonists (LABA) drugs.
Study Finds Breathing Retraining Associated With Quality of Life Improvement for Patients With Asthma
December 14th 2017

Study Finds Breathing Retraining Associated With Quality of Life Improvement for Patients With Asthma

Laura Joszt, MA
Despite effective pharmacology, many patients with asthma have impaired quality of life, but a new breathing retraining intervention can be used as a nonpharmacological intervention to treat asthma.
FDA Announces Public Education Campaign to Encourage Smoking Cessation
December 14th 2017

FDA Announces Public Education Campaign to Encourage Smoking Cessation

Jaime Rosenberg
The FDA has announced its launch of the “Every Try Counts” campaign, which will encourage smokers to quit by advertising messages of support underscoring the health benefits of quitting. The campaign will also focus on celebrating each quit attempt as a step towards success.
Site Logo
December 8th 2017

Implications of DRG Classification in a Bundled Payment Initiative for COPD

Trisha M. Parekh, DO Surya P. Bhatt, MD Andrew O. Westfall, MS James M. Wells, MD deNay Kirkpatrick, DNP, APN-BC Anand S. Iyer, MD Michael Mugavero, MD James H. Willig, MD Mark T. Dransfield, MD
Diagnosis-related group coding determines eligibility for many Medicare bundled payment initiatives. This approach excluded many patients with chronic obstructive pulmonary disease likely to benefit while including others without the disease.
Identifying Differences of Symptoms of Patients With Severe COPD in 3 Countries
December 5th 2017

Identifying Differences of Symptoms of Patients With Severe COPD in 3 Countries

Laura Joszt, MA
A study of patients with severe chronic obstructive pulmonary disease (COPD) in Poland, The Republic of Korea, and the United States identified substantial differences in respiratory symptoms and other respiratory illnesses.
Identifying the Most Prevalent and Costly Chronic Conditions in Medicaid
November 29th 2017

Identifying the Most Prevalent and Costly Chronic Conditions in Medicaid

Laura Joszt, MA
High prevalence of chronic conditions has been a key driver of healthcare costs in the United States, and Medicaid beneficiaries tend to have higher rates of chronic diseases than people not on Medicaid.
Eosinophil Count in Sputum, Not Blood, Is Better Predictor of COPD Severity in Smokers
November 21st 2017

Eosinophil Count in Sputum, Not Blood, Is Better Predictor of COPD Severity in Smokers

Christina Mattina
Data from a study of smokers with chronic obstructive pulmonary disease (COPD) indicate that the concentration of eosinophils in the sputum, rather than the blood, is a better predictor of COPD exacerbations and lung function.
Impact of Symptoms and COPD Severity on Health-Related Quality of Life
November 14th 2017

Impact of Symptoms and COPD Severity on Health-Related Quality of Life

Laura Joszt, MA
Chronic obstructive pulmonary disease (COPD) is characterized by persistent and progressive airflow limitation, and a new study examined the factors responsible for a high St George’s Respiratory Questionnaire for COPD based on severity of airflow limitation.
Long-Term Oxygen Therapy Can Improve Survival in Patients With Oxygen-Dependent COPD
November 9th 2017

Long-Term Oxygen Therapy Can Improve Survival in Patients With Oxygen-Dependent COPD

Surabhi Dangi-Garimella, PhD
A new study has shown that long-term oxygen therapy in patients with severe alpha-1 antitrypsin deficiency can improve survival; however, their outcomes do not improve following lung-transplantation.
Study Finds a 47% Increased Risk of COPD Hospitalization Among RA Patients
November 1st 2017

Study Finds a 47% Increased Risk of COPD Hospitalization Among RA Patients

Alison Rodriguez
Previous studies have revealed a potential connection between chronic inflammatory conditions and the predisposition of chronic obstructive pulmonary disease (COPD), and a new study has found that patients with rheumatoid arthritis (RA) are associated with a greater risk of COPD hospitalization compared to the general population.
Study Investigates New COPD Categories With GOLD 2017
October 26th 2017

Study Investigates New COPD Categories With GOLD 2017

Alison Rodriguez
New high-risk groups of patients with chronic obstructive pulmonary disease according to GOLD 2017 were found to have more characteristics related to acute exacerbation and mortality risks.
Site Logo
October 4th 2017

Study Links Anxiety and Depression Symptoms to COPD Patients and Caregivers

Alison Rodriguez
Patients suffering from chronic obstructive pulmonary disease and their caretakers may experience symptoms of anxiety and depression that could impact their mortality, quality of life, and healthcare use.
Site Logo
September 26th 2017

Chronic Respiratory Disease Death Toll Rising in Recent Decades

Christina Mattina
A new analysis finds that the mortality rate from chronic respiratory diseases has risen by almost 30% between 1980 and 2014 in the United States, and that data reflect significant differences in death rates across counties and regions.
Site Logo
August 1st 2017

Gastric Bypass Sharply Lowers Death Risk for People With Diabetes, Study Finds

Mary Caffrey
The reduced mortality risk was not seen in patients who did not have diabetes before surgery. But in those who did, the results were dramatic.
Site Logo
May 23rd 2017

Adding Home-Based Ventilation to COPD Therapy Can Prolong Time to Readmission, Death

Christina Mattina
A JAMA study has found that patients with chronic obstructive pulmonary disease (COPD) who received noninvasive ventilation in addition to home oxygen therapy went longer without being readmitted to the hospital or dying than those who received only home oxygen therapy.
Site Logo
March 17th 2017

Catching a Cold Poses Risk of Symptom Exacerbation in COPD Patients

Christina Mattina
For patients with chronic obstructive pulmonary disease (COPD), catching a cold is often more than just an annoyance; their risk of experiencing COPD symptom exacerbation rises 30-fold when they exhibit signs of a cold.
Site Logo
February 18th 2017

New Collaboration to Promote Discovery of Innovative Respiratory Therapies

Christina Mattina
Weill Cornell Medicine and Boehringer Ingelheim have announced a collaboration that will investigate novel approaches to treating chronic respiratory disease.
Site Logo
January 9th 2014

Smoking and Health at 50: A Public Health Milestone

EBRC takes a special look at Smoking and Health, the 1964 report to the Surgeon General that forever changed how this country thought about cigarettes, on the eve of its 50th anniversary.
Site Logo
October 11th 2013

Express Scripts Stops Covering Key Big Pharma Drugs on Clinical, Cost-Effectiveness Grounds

A few weeks ago, Novo Nordisk ($NVO) said it had lost Express Scripts' business on two of its top drugs, Victoza and NovoLog. Well, that was just part of the action at the pharmacy benefits manager.
Site Logo
June 26th 2013

Climate Change Bill Gives Hope to Help Asthma, Other Ills

<1
...
171819202122>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo